Saturday 17 October 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024. In the quarter to June 2026, revenue grew 19.9%, EPS fell 81.6%, free cash flow fell 20.3% and total debt rose 602.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

54.68 1.37 −2.44%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 144×
Fwd P/E: 16.1×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	1.18%	4.48%	5.94%	9.07%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	4	5	8
ROA Full definition →	0.76%	3.42%	4.79%	7.20%
ROIC Full definition →	0.97%	3.64%	5.00%	7.43%
Return on Tangible Assets Full definition →	2.21%	5.63%	8.41%	12.71%
Average Days of Receivables Full definition →	113.69	101.76	102.91	93.23
Free Cash Flow per Share Full definition →	3.75	3.98	3.74	4.30
Free Cash Flow Full definition →	724.81	767.06	717.02	825.79
Capital Expenditures Full definition →	(132.28)	(107.19)	(110.97)	(88.18)
Other line items
Cash ROIC Full definition →	6.37%	7.78%	8.70%	10.16%
Accounts Receivable Turnover Full definition →	3.55	3.95	4.11	3.95
Accounts Payable Turnover Full definition →	0.96	1.07	1.05	0.76
Inventory Turnover Full definition →	0.52	0.60	0.57	0.45
Average Days of Payables Full definition →	451.23	380.48	386.16	504.32
Days of Inventory on Hand Full definition →	799.69	610.77	660.81	873.02
Tax Rate Full definition →	(0.51)	(0.30)	(0.28)	(0.23)
Research and Development Expense of Revenue Full definition →	28.99%	29.05%	28.62%	29.19%
Selling, General and Administrative Expense of Revenue Full definition →	40.17%	37.17%	35.79%	31.46%
Share Based Compensation of Revenue Full definition →	6.32%	5.77%	5.63%	6.03%
Interest Coverage Full definition →	1.79	13.71	37.57	57.53
Operating CF/Net income Full definition →	11.75	3.25	2.37	1.76
Depreciation/Fixed assets Full definition →	0.15	0.07	0.08	0.07
Capex/Depreciation Full definition →	(0.89)	(1.53)	(1.48)	(1.14)
Revenue per Share Full definition →	17.61	16.84	16.80	16.11
Operating CF per Share Full definition →	4.43	4.54	4.32	4.76
Capex per Share Full definition →	(0.68)	(0.56)	(0.58)	(0.46)
Capex to Sales Full definition →	0.04	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly